Patent ID: 11952376
Assignee: PLIANT THERAPEUTICS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 102:
103. The compound of claim 102, or a pharmaceutically acceptable salt, stereoisomer, or tautomer thereof, wherein:
R3 is 5- to 10-membered heteroaryl, wherein the 5- to 10-membered heteroaryl is optionally substituted by 1, 2, 3, 4, or 5 independently selected 0-5 R3e substituents; and
each R3e is independently halogen, C1-C6 alkyl, OC1-C6 alkyl, or 5- to 10-membered heteroaryl, wherein each C1-C6 alkyl is optionally and independently substituted by 1 or more independently selected halogen substituents, and further wherein each 5- to 10-membered heteroaryl is optionally and independently substituted by 1 or more independently selected from the group consisting of halogen and C1-C6 alkyl.